233 related articles for article (PubMed ID: 25546225)
21. 18F-FDG and 18F-NaF PET/CT Findings of a Multiple Myeloma Patient With Thyroid Cartilage Involvement.
Oral A; Yazici B; Ömür Ö; Comert M; Saydam G
Clin Nucl Med; 2015 Nov; 40(11):873-6. PubMed ID: 26204214
[TBL] [Abstract][Full Text] [Related]
22. Assessment of blood pool, soft tissue, and skeletal uptake of sodium fluoride F 18 with positron emission tomography-computed tomography in four clinically normal dogs.
Valdés-Martínez A; Kraft SL; Brundage CM; Arceneaux BK; Stewart JA; Gibbons DS
Am J Vet Res; 2012 Oct; 73(10):1589-95. PubMed ID: 23013185
[TBL] [Abstract][Full Text] [Related]
23. Incidental brain metastasis of breast cancer detected on 18F-Sodium Fluoride (NaF) PET-CT.
Usmani S; Ahmed N; Muzaffar S; Kandari FA
J Pak Med Assoc; 2020 Oct; 70(10):1867-1868. PubMed ID: 33159774
[TBL] [Abstract][Full Text] [Related]
24. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
Xu F; Liu F; Pastakia B
Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a short dynamic 18F-fluoride PET/CT scanning method to assess bone metabolic activity in spinal orthopedics.
Peters MJ; Wierts R; Jutten EM; Halders SG; Willems PC; Brans B
Ann Nucl Med; 2015 Nov; 29(9):799-809. PubMed ID: 26243500
[TBL] [Abstract][Full Text] [Related]
26. [Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Lapa P; Saraiva T; Silva R; Marques M; Costa G; Lima JP
Acta Med Port; 2017 Jan; 30(1):53-60. PubMed ID: 28501038
[TBL] [Abstract][Full Text] [Related]
27. A proof-of-concept study analyzing the clinical utility of fluorine-18-sodium fluoride PET-CT in skeletal staging of oncology patients with end-stage renal disease on dialysis.
Usmani S; Marafi F; Esmail A; Ahmed N
Nucl Med Commun; 2017 Dec; 38(12):1067-1075. PubMed ID: 28953207
[TBL] [Abstract][Full Text] [Related]
28. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Roop MJ; Singh B; Singh H; Watts A; Kohli PS; Mittal BR; Singh G
Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210
[TBL] [Abstract][Full Text] [Related]
29. Bone metastases diagnosis possibilities in studies with the use of 18F-NaF and 18F-FDG.
Tarnawska-Pierścińska M; Hołody Ł; Braziewicz J; Królicki L
Nucl Med Rev Cent East Eur; 2011; 14(2):105-8. PubMed ID: 22219151
[TBL] [Abstract][Full Text] [Related]
30. The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.
Kurdziel KA; Shih JH; Apolo AB; Lindenberg L; Mena E; McKinney YY; Adler SS; Turkbey B; Dahut W; Gulley JL; Madan RA; Landgren O; Choyke PL
J Nucl Med; 2012 Aug; 53(8):1175-84. PubMed ID: 22728263
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of bone 18F-NaF deposition.
Czernin J; Satyamurthy N; Schiepers C
J Nucl Med; 2010 Dec; 51(12):1826-9. PubMed ID: 21078790
[TBL] [Abstract][Full Text] [Related]
32. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
33. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
[TBL] [Abstract][Full Text] [Related]
34. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
[TBL] [Abstract][Full Text] [Related]
35. Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Jackson T; Mosci C; von Eyben R; Mittra E; Ganjoo K; Biswal S; Gambhir SS; Iagaru A
Clin Nucl Med; 2015 Sep; 40(9):720-4. PubMed ID: 26053718
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.
Beheshti M; Rezaee A; Geinitz H; Loidl W; Pirich C; Langsteger W
J Nucl Med; 2016 Oct; 57(Suppl 3):55S-60S. PubMed ID: 27694173
[No Abstract] [Full Text] [Related]
37. Glioblastoma multiforme metastastic to the bone: diagnosis by (18)F-NaF PET/CT.
Derlin T; Clauditz TS; Bannas P
Clin Nucl Med; 2014 Feb; 39(2):188-9. PubMed ID: 24300358
[TBL] [Abstract][Full Text] [Related]
38. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
39. Automated classification of benign and malignant lesions in
Perk T; Bradshaw T; Chen S; Im HJ; Cho S; Perlman S; Liu G; Jeraj R
Phys Med Biol; 2018 Nov; 63(22):225019. PubMed ID: 30457118
[TBL] [Abstract][Full Text] [Related]
40. Temporal relationship between
Nakahara T; Narula J; Fox JJ; Jinzaki M; Strauss HW
J Nucl Cardiol; 2021 Oct; 28(5):1936-1945. PubMed ID: 31741329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
